Medical marketing news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Commentary: Attacks on 340B program distract from source of drug-pricing problem Given all the good things hospitals accomplish thanks to 340B Drug Pricing Program savings—from affordable medications to comprehensive services for the poor—it might seem odd the program has taken so much heat lately. But if you consider the larger context of the attacks—the national debate on runaway drug prices—you’ll understand why drugmakers have worked so hard ... Read More
Public perception is tough to overcome in battle against opioid addiction Three years ago, Rhode Island expanded its treatment of inmates with drug abuse problems. They were given buprenorphine, methadone and naltrexone and counseling up to a year. When released, they were referred to therapy within the community. “It was quite an expansion to what we had already been doing,” said Lauranne Howard, substance abuse coordinator for ... Read More
Building trust through technology for medication adherence The directions are usually pretty basic: Take 1 tablet once a day with water. Simple, right? For eons, providers, payers and pharmacists have resorted to good old-fashioned trust and assumed that the patient was following those simple instructions. Advertisement After all, it’s hard to keep a constant eye on patients when they are at home. But trust alone doesn’t ... Read More
Scots ban cheap booze in public health move The land where Scotch whisky was born has introduced a long-debated public health initiative—discouraging problem drinking by setting minimum prices for booze. Beginning this month, retailers were required to charge at least 50 pence (68 cents) per unit, with a unit equivalent to about half a pint of beer or a small glass of wine. According to ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
The Great DTC Shake-Up Patient perspectives on direct-to-consumer advertising This in-depth eyeforpharma whitepaper, which we developed with Health Perspectives Group explores the evolving role of DTC advertising with direct feedback from patient’s – including exclusive results from the recent “DTC Attitudes, Behaviours and Preferences” patient study conducted by Health Stories Project – Insights, (HSPi). Read More